Misawa T
First Department of Surgery, Jikei University School of Medicine.
Nihon Shokakibyo Gakkai Zasshi. 1991 Oct;88(10):2653-62.
Liver cirrhosis was induced in rats by administering thioacetamide (TAA), and portal hypertension was maintained for at most 35 weeks to study the influence of portal hypertension on the weight of spleen and splenic tissues. TAA was intraperitoneally injected at dose of 200 mg/kg three times a week. The portal pressure was elevated and the weight of the spleen increased with the progression of hepatic fibrosis due to TAA. Liver cirrhosis was obviously observed after TAA was administered 60 times. The maximum ratio of the weight of the spleen to body weight in the group administered TAA was higher by 4.08 times than that in the control group. In all 49 rats used in the experiment there was a high correlation (r = 0.930, p less than 0.01) between the portal pressure and the ratio of spleen to body weight. Histological observation revealed that the red pulp tended to be enlarged, while the white pulp tended to be reduced, with increases in portal pressure and weight of the spleen. It also histologically revealed an increase in the splenic sinus-like structure, narrowing of the splenic cords, fibrosis due to reticular cell proliferation in the red pulp and fibrosis around the central artery in the white pulp. These histological changes in rats were similar to the histological findings of splenomegaly accompanying portal hypertension in humans. This suggests that the animal model prepared in the present experiment is useful as a model of splenomegaly due to portal hypertension.
通过给予硫代乙酰胺(TAA)诱导大鼠肝硬化,并维持门静脉高压最多35周,以研究门静脉高压对脾脏重量和脾组织的影响。TAA以200mg/kg的剂量每周腹腔注射3次。随着TAA所致肝纤维化的进展,门静脉压力升高,脾脏重量增加。给予TAA 60次后明显观察到肝硬化。TAA给药组脾脏重量与体重的最大比值比对照组高4.08倍。在实验所用的全部49只大鼠中,门静脉压力与脾脏与体重的比值之间存在高度相关性(r = 0.930,p < 0.01)。组织学观察显示,随着门静脉压力和脾脏重量增加,红髓趋于增大,而白髓趋于缩小。组织学还显示脾窦样结构增加、脾索变窄、红髓中网状细胞增殖导致的纤维化以及白髓中中央动脉周围的纤维化。大鼠的这些组织学变化与人门静脉高压伴脾肿大的组织学表现相似。这表明本实验制备的动物模型可作为门静脉高压所致脾肿大的模型。